🚀 VC round data is live in beta, check it out!
Waldencast Valuation Multiples
Discover revenue and EBITDA valuation multiples for Waldencast and similar public comparables like Shaver Shop Group, IEVA Group, CLIO Cosmetics, Medifast and more.
Waldencast Overview
About Waldencast
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Founded
2020
HQ
Employees
335
Website
Sectors
Financials (LTM)
EV
$253M
Waldencast Financials
Waldencast reported last 12-month revenue of $278M and EBITDA of $22M.
In the same LTM period, Waldencast generated $196M in gross profit, $22M in EBITDA, and had net loss of ($197M).
Revenue (LTM)
Waldencast P&L
In the most recent fiscal year, Waldencast reported revenue of $272M and EBITDA of $20M.
Waldencast expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $278M | XXX | $272M | XXX | XXX | XXX |
| Gross Profit | $196M | XXX | $183M | XXX | XXX | XXX |
| Gross Margin | 70% | XXX | 67% | XXX | XXX | XXX |
| EBITDA | $22M | XXX | $20M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| EBIT Margin | (44%) | XXX | (24%) | XXX | XXX | XXX |
| Net Profit | ($197M) | XXX | ($230M) | XXX | XXX | XXX |
| Net Margin | (71%) | XXX | (84%) | XXX | XXX | XXX |
| Net Debt | — | — | $106M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Waldencast Stock Performance
Waldencast has current market cap of $134M, and enterprise value of $253M.
Market Cap Evolution
Waldencast's stock price is $1.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $253M | $134M | 0.0% | XXX | XXX | XXX | $-1.79 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWaldencast Valuation Multiples
Waldencast trades at 0.9x EV/Revenue multiple, and 11.7x EV/EBITDA.
EV / Revenue (LTM)
Waldencast Financial Valuation Multiples
As of April 20, 2026, Waldencast has market cap of $134M and EV of $253M.
Equity research analysts estimate Waldencast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Waldencast has a P/E ratio of (0.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $134M | XXX | $134M | XXX | XXX | XXX |
| EV (current) | $253M | XXX | $253M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 11.7x | XXX | 12.8x | XXX | XXX | XXX |
| EV/EBIT | (2.1x) | XXX | (3.9x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.3x | XXX | 1.4x | XXX | XXX | XXX |
| P/E | (0.7x) | XXX | (0.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (15.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Waldencast Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Waldencast Margins & Growth Rates
Waldencast's revenue in the last 12 month grew by 7%.
Waldencast's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.7M for the same period.
Waldencast's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Waldencast's rule of X is 27% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Waldencast Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 32% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 91% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Waldencast Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Waldencast | XXX | XXX | XXX | XXX | XXX | XXX |
| Shaver Shop Group | XXX | XXX | XXX | XXX | XXX | XXX |
| IEVA Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CLIO Cosmetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Medifast | XXX | XXX | XXX | XXX | XXX | XXX |
| Beauty Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Waldencast M&A Activity
Waldencast acquired XXX companies to date.
Last acquisition by Waldencast was on XXXXXXXX, XXXXX. Waldencast acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Waldencast
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialWaldencast Investment Activity
Waldencast invested in XXX companies to date.
Waldencast made its latest investment on XXXXXXXX, XXXXX. Waldencast invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Waldencast
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Waldencast
| When was Waldencast founded? | Waldencast was founded in 2020. |
| Where is Waldencast headquartered? | Waldencast is headquartered in United States. |
| How many employees does Waldencast have? | As of today, Waldencast has over 335 employees. |
| Who is the CEO of Waldencast? | Waldencast's CEO is Michel Brousset. |
| Is Waldencast publicly listed? | Yes, Waldencast is a public company listed on Nasdaq. |
| What is the stock symbol of Waldencast? | Waldencast trades under WALD ticker. |
| When did Waldencast go public? | Waldencast went public in 2021. |
| Who are competitors of Waldencast? | Waldencast main competitors are Shaver Shop Group, IEVA Group, CLIO Cosmetics, Medifast. |
| What is the current market cap of Waldencast? | Waldencast's current market cap is $134M. |
| What is the current revenue of Waldencast? | Waldencast's last 12 months revenue is $278M. |
| What is the current revenue growth of Waldencast? | Waldencast revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Waldencast? | Current revenue multiple of Waldencast is 0.9x. |
| Is Waldencast profitable? | Yes, Waldencast is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Waldencast? | Waldencast's last 12 months EBITDA is $22M. |
| What is Waldencast's EBITDA margin? | Waldencast's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Waldencast? | Current EBITDA multiple of Waldencast is 11.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.